Leaflet HYDREA 500mg capsules
Indicated for: myeloproliferative neoplasms; sickle cell disease
Route of administration: oral
Substance: hydroxycarbamide (antineoplastic agent)
ATC: L01XX05 (Antineoplastic and immunomodulating agents | Other antineoplastic agents)
This medicine may affect fertility.
Dose adjustment may be needed in liver disease.
Handle with special care.
Effective contraception is required during treatment.
Do not use this medicine while breastfeeding.
Do not use this medicine during pregnancy.
This medicine may affect the liver.
This medicine may have important interactions with other medicines.
This medicine may lower blood cell counts.
This medicine is subject to additional monitoring.
Periodic laboratory tests may be required during treatment.
Stop taking the medicine and seek urgent medical help if a severe rash occurs.
Hydroxyurea is a medication used to treat certain types of cancer, such as chronic myeloid leukemia, and other conditions like sickle cell anemia. It works by inhibiting DNA synthesis, which slows the growth of cancerous or abnormal cells.
The medication is taken orally, as directed by a doctor.
Side effects may include nausea, vomiting, decreased blood cell counts, fatigue, or skin rashes. In rare cases, severe allergic reactions or hematologic toxicity may occur.
Patients should be closely monitored during treatment and inform their doctor about any other medications they are taking. Pregnant or breastfeeding women should not use this medication.
General data about HYDREA 500mg
- Substance: hydroxycarbamide
- Date of latest medicines list: 01-06-2026
- Product code: W03542001
- Concentration: 500mg
- Pharmaceutical form: capsules
- Quantity: 100
- Product type: Original
- Price: 121.69 RON
- Prescription status: P-RF - Medicines dispensed with a medical prescription that is retained by the pharmacy and cannot be renewed.
Pharmaceutical forms available for hydroxycarbamide
Concentrations available for hydroxycarbamide
- 1000mg
- 500mg